Biotechnology TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer – TransCode Therapeutics (NASDAQ:RNAZ) Read more
Biotechnology Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer Read more